Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

160 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Towards a science-based testing strategy to identify maternal thyroid hormone imbalance and neurodevelopmental effects in the progeny - part II: how can key events of relevant adverse outcome pathways be addressed in toxicological assessments?
Marty S, Beekhuijzen M, Charlton A, Hallmark N, Hannas BR, Jacobi S, Melching-Kollmuss S, Sauer UG, Sheets LP, Strauss V, Urbisch D, Botham PA, van Ravenzwaay B. Marty S, et al. Among authors: strauss v. Crit Rev Toxicol. 2021 Apr;51(4):328-358. doi: 10.1080/10408444.2021.1910625. Epub 2021 Jun 2. Crit Rev Toxicol. 2021. PMID: 34074207 Review.
Toward a science-based testing strategy to identify maternal thyroid hormone imbalance and neurodevelopmental effects in the progeny - part I: which parameters from human studies are most relevant for toxicological assessments?
Sauer UG, Asiimwe A, Botham PA, Charlton A, Hallmark N, Jacobi S, Marty S, Melching-Kollmuss S, Palha JA, Strauss V, van Ravenzwaay B, Swaen G. Sauer UG, et al. Among authors: strauss v. Crit Rev Toxicol. 2020 Oct;50(9):740-763. doi: 10.1080/10408444.2020.1839380. Epub 2020 Dec 11. Crit Rev Toxicol. 2020. PMID: 33305658 Review.
Adversity Considerations for Thyroid Follicular Cell Hypertrophy and Hyperplasia in Nonclinical Toxicity Studies: Results From the 6th ESTP International Expert Workshop.
Huisinga M, Bertrand L, Chamanza R, Damiani I, Engelhardt J, Francke S, Freyberger A, Harada T, Harleman J, Kaufmann W, Keane K, Köhrle J, Lenz B, Marty MS, Melching-Kollmuss S, Palazzi X, Pohlmeyer-Esch G, Popp A, Rosol TJ, Strauss V, Van den Brink-Knol H, Wood CE, Yoshida M. Huisinga M, et al. Among authors: strauss v. Toxicol Pathol. 2020 Dec;48(8):920-938. doi: 10.1177/0192623320972009. Toxicol Pathol. 2020. PMID: 33334259
Report from the BfR expert hearing on practicability of hormonal measurements: recommendations for experimental design of toxicological studies with integrated hormonal end points.
Kucheryavenko O, Lurman G, Lehmann A, Braz J, Niemann L, Chahoud I, Mantovani A, Håkansson H, Schneider S, Strauss V, Coder PS, Freyberger A, O'Connor JC, Rauch M, Renko K, Solano MLM, Andersson N, Blanck O, Ritz V, Solecki R. Kucheryavenko O, et al. Among authors: strauss v. Arch Toxicol. 2019 Apr;93(4):1157-1167. doi: 10.1007/s00204-019-02436-3. Epub 2019 Mar 30. Arch Toxicol. 2019. PMID: 30929029
ESTP comments on the draft updated OECD test guideline 407.
Hartmann E, Strauss V, Eiben R, Freyberger A, Kaufmann W, Loof I, Reissmueller E, Rinke M, Ruehl-Fehlert C, Schorsch F, Schladt L. Hartmann E, et al. Among authors: strauss v. Exp Toxicol Pathol. 2008 Mar;59(5):297-300. doi: 10.1016/j.etp.2007.10.007. Epub 2007 Nov 28. Exp Toxicol Pathol. 2008. PMID: 18054214
160 results